Eurofins: Purchases of Own Shares From May 19th to May 23th 2025
LUXEMBOURG–(BUSINESS WIRE)–Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code... Read more.
DEWA Receives Applications From Local and International Companies Seeking to Participate in 27th Edition of WETEX
DUBAI, United Arab Emirates–(BUSINESS WIRE)–Dubai Electricity and Water Authority (DEWA) has started to receive applications for participation in the... Read more.
Europe Data Center GPUs Market Analysis and Forecast Report 2025 | Europe’s Data Center GPU Market to Soar to $82.2B by 2034 with AI and HPC Demand – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Data Center GPUs Market: Focus on Product, Application, and Country – Analysis and Forecast, 2024-2034”... Read more.
TASI® Bank Deepens Commitment to Community Through Nonprofit Partnerships and Financial Literacy Initiatives
SAN FRANCISCO–(BUSINESS WIRE)–TASI® Bank, a San Francisco-based Minority Depository Institution (MDI), today reaffirmed its dedication to supporting... Read more.
BSGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of BioSig Technologies, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of BioSig Technologies, Inc. (NASDAQ: BSGM)... Read more.
AMTD Achieves Another Victory and Further Action Against IP Infringements
PARIS & NEW YORK & SINGAPORE–(BUSINESS WIRE)–AMTD Group Inc. (“AMTD” or the “Group”), alongside The Generation Essentials... Read more.
AMTD Achieves Another Victory and Further Action Against IP Infringements
PARIS & NEW YORK & SINGAPORE–(BUSINESS WIRE)–AMTD Group Inc. (“AMTD” or the “Group”), alongside The Generation Essentials... Read more.
VISTA Inhibitor Clinical Trials Market Insights and Drug Development Opportunities Report 2025-2028 Featuring Aurigene, Curis, Hummingbird Bioscience, Kineta, PharmAbcine, Sensei Biotherapeutics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “VISTA Inhibitor Clinical Trials, Drug Development Opportunities & Patent Insight 2025” report has been added... Read more.
Semler Scientific Inc. (SMLR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces an investigation on behalf of Semler Scientific Inc. (“Semler” or the “Company”)... Read more.
Huonslab Achieves Last-Patient-In (LPI) in Phase 1 Pivotal Study for Recombinant Human Natural Hyaluronidase PH20
Phase 1 Pivotal Study in Korea for HLB3-002 Plans to apply for marketing approval with the MFDS by the 2H 2025 PANGYO, South Korea–(BUSINESS WIRE)–#Allergenicity—Huonslab... Read more.